Science and Research

SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself

The pathogenesis of severe COVID-19 reflects an inefficient immune reaction to SARS-CoV-2. Here we analyze, at the single cell level, plasmablasts egressed into the blood to study the dynamics of adaptive immune response in COVID-19 patients requiring intensive care. Before seroconversion in response to SARS-CoV-2 spike protein, peripheral plasmablasts display a type 1 interferon-induced gene expression signature; however, following seroconversion, plasmablasts lose this signature, express instead gene signatures induced by IL-21 and TGF-β, and produce mostly IgG1 and IgA1. In the sustained immune reaction from COVID-19 patients, plasmablasts shift to the expression of IgA2, thereby reflecting an instruction by TGF-β. Despite their continued presence in the blood, plasmablasts are not found in the lungs of deceased COVID-19 patients, nor does patient IgA2 binds to the dominant antigens of SARS-CoV-2. Our results thus suggest that, in severe COVID-19, SARS-CoV-2 triggers a chronic immune reaction that is instructed by TGF-β, and is distracted from itself.

  • Ferreira-Gomes, M.
  • Kruglov, A.
  • Durek, P.
  • Heinrich, F.
  • Tizian, C.
  • Heinz, G. A.
  • Pascual-Reguant, A.
  • Du, W.
  • Mothes, R.
  • Fan, C.
  • Frischbutter, S.
  • Habenicht, K.
  • Budzinski, L.
  • Ninnemann, J.
  • Jani, P. K.
  • Guerra, G. M.
  • Lehmann, K.
  • Matz, M.
  • Ostendorf, L.
  • Heiberger, L.
  • Chang, H. D.
  • Bauherr, S.
  • Maurer, M.
  • Schönrich, G.
  • Raftery, M.
  • Kallinich, T.
  • Mall, M. A.
  • Angermair, S.
  • Treskatsch, S.
  • Dörner, T.
  • Corman, V. M.
  • Diefenbach, A.
  • Volk, H. D.
  • Elezkurtaj, S.
  • Winkler, T. H.
  • Dong, J.
  • Hauser, A. E.
  • Radbruch, H.
  • Witkowski, M.
  • Melchers, F.
  • Radbruch, A.
  • Mashreghi, M. F.
Publication details
DOI: 10.1038/s41467-021-22210-3
Journal: Nat Commun
Pages: 1961 
Number: 1
Work Type: Original
Location: Assoziierter Partner
Disease Area: PALI
Partner / Member: BIH
Access-Number: 33785765

DZL Engagements

chevron-down